(Q46098047)

English

Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group

scientific article published on 6 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

1 reference

based on heuristic

inferred from title

author name string

Mari Sakai

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yasushi Miyazaki

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Emi Matsuo

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yukiyoshi Moriuchi

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Tomoko Hata

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Takuya Fukushima

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yoshitaka Imaizumi

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Daisuke Imanishi

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Jun Taguchi

9

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Masako Iwanaga

10

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Hideki Tsushima

11

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yoriko Inoue

12

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yumi Takasaki

13

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Takeshi Tsuchiya

14

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Minori Komoda

15

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Koji Ando

16

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Kensuke Horio

17

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yuji Moriwaki

18

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Shinya Tominaga

19

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Hidehiro Itonaga

20

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Kazuhiro Nagai

21

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Kunihiro Tsukasaki

22

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Chizuko Tsutsumi

23

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yasushi Sawayama

24

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Reishi Yamasaki

25

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Daisuke Ogawa

26

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yasuhisa Kawaguchi

27

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Shuichi Ikeda

28

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Shinichiro Yoshida

29

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yasuyuki Onimaru

30

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Masayuki Tawara

31

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Sunao Atogami

32

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Satoshi Koida

33

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Tatsuro Joh

34

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Masaomi Yamamura

35

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Yuji Matsuo

36

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Hisashi Soda

37

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Hiroaki Nonaka

38

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Itsuro Jinnai

39

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Kazutaka Kuriyama

40

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Masao Tomonaga

41

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 March 2009

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

International Journal of Hematology

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

89

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

319-325

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

https://scigraph.springernature.com/pub.10.1007/s12185-009-0263-z

0 references

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib mesylate in the treatment of chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of imatinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19266256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-009-0263-Z

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19266256

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46098047&oldid=2092444149"